KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN has a total of 168 patent applications. It decreased the IP activity by 38.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIVERSITATSKLINIKUM HAMBURG E, IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBH and APPLIED GENETIC TECH CORPORATION.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 24 | |
#2 | United States | 22 | |
#3 | WIPO (World Intellectual Property Organization) | 21 | |
#4 | United Kingdom | 16 | |
#5 | Australia | 15 | |
#6 | Canada | 15 | |
#7 | Republic of Korea | 10 | |
#8 | China | 8 | |
#9 | Singapore | 8 | |
#10 | Israel | 7 | |
#11 | Brazil | 5 | |
#12 | Hungary | 4 | |
#13 | Japan | 4 | |
#14 | Mexico | 4 | |
#15 | Hong Kong | 3 | |
#16 | New Zealand | 1 | |
#17 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Organic fine chemistry | |
#7 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Climate change adaptation technologies | |
#9 | Heterocyclic compounds | |
#10 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Clevers Johannes Carolus | 75 |
#2 | Huch Ortega Meritxell | 41 |
#3 | Sato Toshiro | 23 |
#4 | Geijsen Niels | 16 |
#5 | Sachs Lars Norman | 11 |
#6 | Drost Jarno | 11 |
#7 | Beumer Joep | 8 |
#8 | Ortega Meritxell Huch | 8 |
#9 | Johannes Carolus Clevers | 8 |
#10 | Vries Robert Gerhardus Jacob | 8 |
Publication | Filing date | Title |
---|---|---|
GB202004706D0 | Methods and tools for studying enteroendocrine cells | |
WO2020152210A1 | Tfap2 inhibition for treating cardiac disease involving fibro-fatty replacement | |
WO2020089218A1 | Single cell full length rna sequencing | |
GB201906978D0 | Improved culture method using integrin agonist | |
GB201903573D0 | Culture method for head and neck organoids | |
GB201819224D0 | Hepatocyte expansion methods | |
US2019040033A1 | Method for producing antibiotic from pleosporaceae ulocladium | |
GB201721615D0 | Immune cell organoid co-cultures | |
US2018072995A1 | Culture medium for epithelial stem cells and organoids comprising the stem cells | |
GB201708330D0 | Fusion protein for enhancing intestinal regeneration | |
WO2017061861A1 | Targeted locus amplification using cloning strategies | |
GB201610748D0 | Improved diffrentation method | |
GB201603569D0 | Improved differentiation method | |
GB201521101D0 | Transduction buffer | |
US2017342129A1 | Protein Comprising a Collagen Domain of CCBE1 and Uses Thereof | |
EP3174867A1 | Novel antibiotic | |
US2017191030A1 | Culture method for organoids | |
GB201421094D0 | Culture medium | |
GB201421092D0 | Culture medium | |
GB201408764D0 | Improved culture method for organoids |